Allegheny General Hospital First in Western PA to Participate in Clinical Trial Using Artificial Intelligence to Detect Deep Vein Thrombosis in Cardiac Patients
HCPLive
MARCH 27, 2025
The AI-powered trial was officially initiated in January 2025.
This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
HCPLive
MARCH 27, 2025
The AI-powered trial was officially initiated in January 2025.
DAIC
MARCH 24, 2025
tim.hodson Mon, 03/24/2025 - 15:48 March 24, 2025 Imperative Care, Inc. The catheter is designed to elevate care for patients with venous thrombosis, a serious condition caused by a blood clot forming in the veins of the legs or abdomen that can have a life-threatening impact if left untreated. recently announced U.S.
Stroke Journal
JANUARY 30, 2025
Stroke, Volume 56, Issue Suppl_1 , Page ATP268-ATP268, February 1, 2025. Introduction:Xylitol, a sugar alcohol with a global market estimated at 161,500 metric tons, has been linked to increased thrombosis and risk of stroke and heart attack. The mean BMI was 35.2 kg/m2, HbA1c was 5.9% 0.4,
Circulation: Cardiovascular Interventions
FEBRUARY 17, 2025
Circulation: Cardiovascular Interventions, Volume 18, Issue 2 , Page e014523, February 1, 2025. BACKGROUND:Hypoattenuated leaflet thickening (HALT) is believed to reflect leaflet thrombosis; however, no systematic histological examination of HALT has ever been performed.
Circulation
JANUARY 27, 2025
Circulation, Volume 151, Issue 12 , Page 835-846, March 25, 2025. The risk of stent thrombosis is particularly increased during the first 6 months after intervention. Key exclusion criteria included <18 or >75 years of age, contraindications to anticoagulant use, or acute venous thrombosis <3 months.
DAIC
MARCH 31, 2025
tim.hodson Mon, 03/31/2025 - 16:38 March 29, 2025 Anthos Therapeutics, Inc., 2025 If you enjoy this content, please share it with a colleague presented two new analyses from itsAZALEA-TIMI 71 study at the American College of Cardiology Annual Scientific Session (ACC.25) 2021 4 Hsu et al. J Am Coll Cardiol. J Thromb Haemost.
Circulation
APRIL 6, 2025
Circulation, Volume 151, Issue 14 , Page e922-e922, April 8, 2025.
Stroke Journal
JANUARY 30, 2025
Stroke, Volume 56, Issue Suppl_1 , Page AWP143-AWP143, February 1, 2025. Introduction:The majority of patients with cerebral venous thrombosis (CVT) achieve functional independence (modified Rankin Score [mRS] 0-2), although many continue to experience residual symptoms that negatively impact quality of life.
Cardiometabolic Health Congress
NOVEMBER 25, 2024
On-demand access is available now and will remain open until December 2025. Dyslipidemia, Atherosclerosis & Thrombosis: Explore non-statin therapies, strategies for managing hypertriglyceridemia, and new guidance on lipoprotein(a) management. When Will It Be Available? Ready to Access CMHC On-Demand?
Stroke Journal
JANUARY 30, 2025
Stroke, Volume 56, Issue Suppl_1 , Page ATMP85-ATMP85, February 1, 2025. Introduction:Neonatal deep medullary vein (DMVT) is an increasingly recognized etiology of brain injury in term and preterm infants.
Stroke Journal
JANUARY 30, 2025
Stroke, Volume 56, Issue Suppl_1 , Page ATMP96-ATMP96, February 1, 2025. Direct oral anticoagulants (DOACs) are approved in many countries for the treatment and prevention of pediatric venous thrombosis but its use in pediatric arterial thrombosis is less established. Data was de-identified and SAS 8.3 was used for analysis.
Stroke Journal
NOVEMBER 27, 2024
Stroke, Volume 56, Issue 1 , Page 5-13, January 1, 2025. BACKGROUND:Lack of a dedicated thrombectomy device for cerebral venous thrombosis hinders the recanalization ability of endovascular treatment (EVT). Novel NiTi-braided stent retriever (Venous-TD) is a dedicated venous sinus thrombectomy device.
Stroke Journal
JANUARY 30, 2025
Stroke, Volume 56, Issue Suppl_1 , Page ATMP116-ATMP116, February 1, 2025. Additionally, db/db mice treated with db-gut-EVs exhibited increased cerebral vascular thrombosis (182 vs 112 Fibrin+ vessels/mm2in saline, p<0.05, n=5/group), whereas db/db mice treated with dm-gut-EVs showed a reduction of thrombosis (50.5
Stroke Journal
JANUARY 30, 2025
Stroke, Volume 56, Issue Suppl_1 , Page AWP355-AWP355, February 1, 2025. The change in thrombosis only occurred when mice were pre-exposed to red light. Furthermore, red light had no effect on thrombosis in blind Vsx2orJ/J mice. Introduction:Variations in light exposure are associated with changes in inflammation.
DAIC
FEBRUARY 18, 2025
tim.hodson Tue, 02/18/2025 - 16:41 Feb. The dataset suggests tracking clinic-reported outcome measures at six months within the first year after diagnosis and annually thereafter, and patient-reported outcomes annually, with more frequent tracking advised for patients who undergo either a surgical or transcatheter procedure.
Stroke Journal
JANUARY 30, 2025
Stroke, Volume 56, Issue Suppl_1 , Page AWP260-AWP260, February 1, 2025. L), intravenous thrombolysis was associated with a reduced number of thrombectomy device passes.Conclusions:Fibrinogen plays a significant role in facilitating thrombosis and the occurrence of LVOS in patients with ICAS.
Stroke Journal
JANUARY 30, 2025
Stroke, Volume 56, Issue Suppl_1 , Page ATP366-ATP366, February 1, 2025.
Stroke Journal
JANUARY 26, 2025
Stroke, Volume 56, Issue 2 , Page 527-532, February 1, 2025. Neutrophil extracellular traps (NETs), associated with poor outcomes and reperfusion resistance, contribute to thrombosis. Neutrophil extracellular traps (NETs), associated with poor outcomes and reperfusion resistance, contribute to thrombosis.
Stroke Journal
JANUARY 30, 2025
Stroke, Volume 56, Issue Suppl_1 , Page ATP201-ATP201, February 1, 2025. Background:Patients with intracerebral hemorrhage (ICH) are known to have a higher risk of venous thromboembolism (VTE) than patients with acute ischemic stroke, but the factors underlying this difference have not been clearly identified.
Stroke Journal
JANUARY 30, 2025
Stroke, Volume 56, Issue Suppl_1 , Page ADP36-ADP36, February 1, 2025. All patients had headache, and funduscopic examination demonstrated papilledema for all patients.
Stroke Journal
JANUARY 30, 2025
Stroke, Volume 56, Issue Suppl_1 , Page AWP134-AWP134, February 1, 2025. Introduction:Stroke is a leading cause of maternal morbidity and mortality, and hemorrhagic strokes account for up to half of these cases. Prior studies in non-maternal populations demonstrated that 9% of strokes are missed at initial ED presentation.
Stroke Journal
JANUARY 30, 2025
Stroke, Volume 56, Issue Suppl_1 , Page AWMP59-AWMP59, February 1, 2025. Background and Purpose:External counterpulsation (ECP) is a novel noninvasive method used to improve the perfusion of vital organs, which may benefit ischemic stroke patients.
Stroke Journal
JANUARY 30, 2025
Stroke, Volume 56, Issue Suppl_1 , Page ATP67-ATP67, February 1, 2025. Topics covered included early recognition, acute management, hemorrhagic stroke, cerebral venous sinus thrombosis (CVST), etc. The challenge often is how to continue to meet the education requirements in an effective and timely format.
Stroke Journal
JANUARY 30, 2025
Stroke, Volume 56, Issue Suppl_1 , Page ATMP43-ATMP43, February 1, 2025. Background:Disparities in anticoagulation therapy, driven by race, age, and insurance status, affect access to direct oral anticoagulants (DOACs). Patients were drawn from neurology, cardiology, and other services.
Stroke Journal
JANUARY 30, 2025
Stroke, Volume 56, Issue Suppl_1 , Page ATMP16-ATMP16, February 1, 2025. Elevated levels of Lp(a) are an independent and causal risk factor for atherosclerotic cardiovascular diseases through mechanisms associated with increased atherogenesis, inflammation, and thrombosis.
Stroke Journal
JANUARY 30, 2025
Stroke, Volume 56, Issue Suppl_1 , Page ATMP117-ATMP117, February 1, 2025. VWF traps platelets, and excessive VWF activation leads to thrombosis. Introduction:Despite timely recanalization, some ischemic stroke patients treated with endovascular thrombectomy experience persistent neurological deterioration.
Stroke Journal
JANUARY 30, 2025
Stroke, Volume 56, Issue Suppl_1 , Page A151-A151, February 1, 2025. Eligible patients were between ages 18-50 years, with a confirmed diagnosis of arterial ischemic stroke (AIS), intracerebral hemorrhage (ICH), subarachnoid hemorrhage (SAH) or cerebral venous thrombosis (CVT) between 01/01/2012 and 12/31/2021.
Stroke Journal
JANUARY 30, 2025
Stroke, Volume 56, Issue Suppl_1 , Page ATP39-ATP39, February 1, 2025. None of the patients developed tissue/neurovascular injury or deep vein thrombosis. Background:Cerebral small vessel disease (CSVD) is a leading cause of vascular cognitive impairment (VCI). vs once-daily:1.6, mL, 95%CI -0.54-0.13).
Stroke Journal
JANUARY 30, 2025
Stroke, Volume 56, Issue Suppl_1 , Page ATMP111-ATMP111, February 1, 2025. Introduction:VWF is an endothelial protein with known roles in hemostasis and thrombosis. We previously demonstrated abnormal deposition of VWF in themurallayer of leptomeningeal collateral arterioles (LMCs) during flow-induced outward remodeling.
Stroke Journal
JANUARY 30, 2025
Stroke, Volume 56, Issue Suppl_1 , Page AWP328-AWP328, February 1, 2025. Adverse vascular outcomes used as endpoints include acute ischemic stroke, acute myocardial infarction, deep vein thrombosis/pulmonary embolism, AF, and carotid artery dissection.A Patients with any adverse vascular outcomes before the index ECG were excluded.
DAIC
APRIL 2, 2025
Stone, MD Mount Sinai Health System tim.hodson Wed, 04/02/2025 - 15:26 March 31, 2025 Using intravascular imaging (IVI) to guide stent implantation during complex stenting procedures is safer and more effective for patients with severely calcified coronary artery disease than conventional angiography, the more commonly used technique.
Stroke Journal
JANUARY 30, 2025
Stroke, Volume 56, Issue Suppl_1 , Page AWP299-AWP299, February 1, 2025. Background:Newer Oral Anticoagulants (NOACs) offer potential advantages for patients with cerebral venous sinus thrombosis (CVST). However, there is a lack of evidence to evaluate the efficacy and safety of NOACs in CVST. vs 8.0%, P=0.014) and mRS2 (95.1%
Stroke Journal
JANUARY 30, 2025
Stroke, Volume 56, Issue Suppl_1 , Page AWP364-AWP364, February 1, 2025. proposed an innovative thromboembolic stroke model in mice where murine thrombin is injected into the M2 segment of the middle cerebral artery (MCA) to induce arterial thrombosis. Introduction:In 2007, Orset et al.
Stroke Journal
DECEMBER 9, 2024
Stroke, Volume 56, Issue 1 , Page 190-193, January 1, 2025. BACKGROUND:The presence of antiphospholipid antibodies (aPL) has been suggested as a potential cause of moyamoya angiopathy (MMA), but this remains uncertain.
Stroke Journal
JANUARY 30, 2025
Stroke, Volume 56, Issue Suppl_1 , Page ATP7-ATP7, February 1, 2025. Introduction:Venous thromboembolism (VTE)manifesting as deep vein thrombosis (DVT) and pulmonary embolus (PE) and arterial thromboembolism (ATE) manifesting as acute ischemic stroke (AIS) result in ~1 million US deaths annually.
Stroke Journal
JANUARY 30, 2025
Stroke, Volume 56, Issue Suppl_1 , Page AWP291-AWP291, February 1, 2025.
Clinical Trial Results
MARCH 29, 2025
Disclosures: TBD
Dr. Smith's ECG Blog
JANUARY 21, 2025
This was most likely acute thrombosis of a coronary artery resulting in OMI: The ECG changes were attributed to hyperkalemia. Negative trops and negative angiogram does not rule out coronary ischemia or ACS. The dye don't lie".except except when it does. Angiogram Negative, or is it?
Dr. Smith's ECG Blog
MARCH 8, 2025
Angiography was technically challenging as the patient was receiving CPR, but the cardiologist suspected acute stent thrombosis and initiated cangrelor, although no repeat angiography was able to be obtained. During the resuscitation, she received amiodarone 450 mg IV, lidocaine 100 mg IV, and magnesium 6 g IV. & Dawson, D.
Expert insights. Personalized for you.
We have resent the email to
Are you sure you want to cancel your subscriptions?
Let's personalize your content